Literature DB >> 25938379

Recent Concise Viewpoints of Chronic Active Epstein-Barr Virus Infection.

Motohiko Okano1.   

Abstract

Chronic active Epstein-Barr virus infection (CAEBV) is characterized mainly by prolonged or intermittent fever, lymphadenopathy and hepatosplenomegaly without definite underlying diseases at the diagnosis. Patients with CAEBV also may have various life-threatening conditions including hematological, neurological, pulmonary, cardiac, digestive tract, ocular and/or dermal disorders. Additionally, during the course of illness, they often develop hematological malignancies such as T cell, NK cell or B cell lymphoproliferative disorder (LPD) and/or lymphoma. No causative pathogenetic mechanisms have been sufficiently clarified, and additionally no promising efficacious treatment was demonstrated except for the hematopoietic stem cell transplantation (HSCT) in cases who develop T cell or NK cell LPD or lymphoma. This minireview outlines the recent development for the comprehensive viewpoints of CAEBV mainly regarding to virological, immunological, pathological and therapeutical progresses.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25938379     DOI: 10.2174/1573396311666150501002809

Source DB:  PubMed          Journal:  Curr Pediatr Rev        ISSN: 1573-3963


  5 in total

1.  The Oncogenic Role of miR-BART19-3p in Epstein-Barr Virus-Associated Diseases.

Authors:  Qingxun Zhang; Donghua Luo; Zhengde Xie; Hongxuan He; Ziyuan Duan
Journal:  Biomed Res Int       Date:  2020-07-02       Impact factor: 3.411

2.  Comprehensive clinical, biochemical and genetic screening reveals four distinct GBA genotypes as underlying variable manifestation of Gaucher disease in a single family.

Authors:  P Cullufi; M Tabaku; C Beetz; S Tomori; V Velmishi; A Gjikopulli; P Bauer; S Wirth; A Rolfs
Journal:  Mol Genet Metab Rep       Date:  2019-10-26

3.  Case Report: Autoimmune Lymphoproliferative Syndrome vs. Chronic Active Epstein-Barr Virus Infection in Children: A Diagnostic Challenge.

Authors:  Aleksandra Szczawińska-Popłonyk; Elzbieta Grześk; Eyal Schwartzmann; Anna Materna-Kiryluk; Jadwiga Małdyk
Journal:  Front Pediatr       Date:  2021-12-30       Impact factor: 3.418

4.  Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Disorders Manifested as Gastrointestinal Perforations and Skin Lesions: A Case Report.

Authors:  Hai-Juan Xiao; Ji Li; Hong-Mei Song; Zheng-Hong Li; Mei Dong; Xiao-Ge Zhou
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

Review 5.  Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Diseases in Chinese Mainland.

Authors:  Junhong Ai; Zhengde Xie
Journal:  Front Pediatr       Date:  2018-10-09       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.